Thursday 24 June 2010, 19.00-20.30
Forget simple 'gene-for-this' conditions - scientists can
now scan the entire genome to find the many genes that have a small
effect on common conditions such as diabetes and heart disease.
Some hope these studies will lead to better drug treatments, more
accurate risk predictions and even personalised medicine. But is
this likely, or even desirable? And what might the negative
consequences of such studies be?
The Wellcome Debate explored the claims, hope and hype
surrounding the 'new genetics', and asked: to what extent will
whole genome screening shape the future of medicine? Will babies
have their genomes sequenced at birth, as some scientists claim?
Will we be prescribed medicines personalised to our own unique
genetic profiles? The debate also explored the
potentially harmful consequences of unravelling our genetic code,
including issues of privacy, ethics and ownership.
Watch video interviews with the speakers, who put their
cases for where research and investment should best be
concentrated for the benefit of all.
Head of Science, Public Health Genetics Foundation
Director of the Wellcome Trust Centre for Human Genetics
Executive Director of Genewatch UK